Clinical Trial Update: Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee

View source ↗

Summary

Extension study update for participants in the MACI00206 study evaluating MACI for symptomatic articular cartilage defects of the knee; study completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defects of the Knee

Drugs mentioned

• MACI (matrix-induced autologous chondrocyte implantation)

Snippet

Sponsor: Vericel Corporation | Conditions: Articular Cartilage Defects | Status: COMPLETED | Results posted: 2017-04-27